Advances in research on HBV inhibitors based on new targets (1): capsid protein inhibitors / 药学学报
Acta Pharmaceutica Sinica
; (12): 554-565, 2020.
Article
em Zh
| WPRIM
| ID: wpr-820854
Biblioteca responsável:
WPRO
ABSTRACT
Hepatitis B virus (HBV) capsid protein plays an important role in the life cycle, thus becoming an ideal target for drug design. Capsid protein inhibitors can exert a synergistic antiviral effect with nucleoside drugs by inhibiting the replication of HBV. This paper reviews the research progress of capsid protein inhibitors with different structural types from the perspective of medicinal chemistry.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2020
Tipo de documento:
Article